课题基金 / 基金详情

Mechanism behind blindness linked to excess glutamylation

Mechanism behind blindness linked to excess glutamylation
失明背后的机制与过量谷氨酰化有关
批准号:
10314856
负责人:
Rawaa Aljammal
金额:
$4.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-10 至 2023-08-09

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Post-translational modification of proteins play an important role in increasing the complexity and functional diversity of limited set of proteins expressed in the cell. One such interesting and highly significant chemical modification is glutamylation. Protein glutamylation is a post-translational modification (PTM) that adds glutamate to one of the glutamic residues in the C terminus of the protein. Protein Glutamylation is dynamic and controlled by repertoire of enzymes, tubulin tyrosine ligase-Like (TTLLs) that add glutamyl group, and by another family of enzymes called cytosolic carboxypeptidase (CCPs or AGBLs) that cleaves the glutamate. Mutation in one member of deglutamylase family, AGBL5 is linked to inherited blindness in humans. While glutamylation is thought to aid in trafficking of proteins, the mechanism behind the blindness linked to excess glutamylation in not known. This proposal aims to investigate the consequences of excess glutamylation in the rod and cone photoreceptors with a mouse model that lacks AGBL5. This fellowship will help reach my long-term goal of understanding mechanisms behind diseases that afflict humans. The findings from this study will advance our understanding of the mechanism underlying the genetic blindness and human health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金